Long-term Stability of Endogenous B-type Natriuretic Peptide (BNP) and Amino Terminal ProBNP (NT-proBNP) in Frozen Plasma Samples
Overview
Pathology
Affiliations
The aim of the present study was to assess the long-term stability of endogenous B-type natriuretic peptide (BNP) and amino terminal proBNP (NT-proBNP) in plasma samples stored at -20 degrees C without addition of protease inhibitors (e.g., aprotinin). Stability of BNP and NT-proBNP was tested in 60 EDTA plasma samples with BNP values between 30 and 420 pg/ml. Initial BNP and NT-proBNP plasma concentrations were determined within four hours after blood collection using the AxSYM BNP and the Elecsys NT-proBNP assays. Subsequently, all samples were stored at -20 degrees C and were thawed for the second BNP and NT-proBNP determination on the two instruments after one day, 30 days, 60 days, 90 days and 120 days, respectively. Mean recovery (i.e., residual immunoreactivity) of BNP and NT-proBNP expressed in percent of the initial value for the given time interval of storage was calculated. Mean recovery of BNP was less than 70% after one day of storage at -20 degrees C and decreased to less than 50% after two to four months of storage (e.g., recovery of endogenous BNP after three months of storage at -20 degrees C ranging from 0% to 71%). In contrast, mean recovery of NT-proBNP was generally greater than 90%, irrespective of the duration of storage at -20 degrees C (e.g., recovery of endogenous NT-proBNP after three months of storage at -20 degrees C ranging from 91% to 112%). In conclusion, the determination of endogenous BNP with the AxSYM assay using frozen plasma samples may not be valid under the conditions tested. In contrast, NT-proBNP as measured by the Elecsys assay may be stored at -20 degrees C for at least four months without a relevant loss of the immunoreactive analyte.
Novel Biomarkers and Their Role in the Diagnosis and Prognosis of Acute Coronary Syndrome.
Katsioupa M, Kourampi I, Oikonomou E, Tsigkou V, Theofilis P, Charalambous G Life (Basel). 2023; 13(10).
PMID: 37895374 PMC: 10608753. DOI: 10.3390/life13101992.
Belanger M, Kovell L, Turkson-Ocran R, Mukamal K, Liu X, Appel L J Am Heart Assoc. 2023; 12(2):e026684.
PMID: 36628985 PMC: 9939071. DOI: 10.1161/JAHA.122.026684.
Hennig A, Mohr L, Fehr M, Legler M Vet Sci. 2022; 9(2).
PMID: 35202316 PMC: 8880403. DOI: 10.3390/vetsci9020064.
Hadziselimovic E, Greve A, Sajadieh A, Olsen M, Kesaniemi Y, Nienaber C JAMA Cardiol. 2022; 7(4):435-444.
PMID: 35171199 PMC: 8851368. DOI: 10.1001/jamacardio.2021.5916.
N-Terminal Pro Brain Natriuretic Peptide, sST2, and Galectin-3 Levels in Breast Cancer Survivors.
Patel S, Herrmann J, Vierkant R, Olson J, Couch F, Hazim A J Clin Med. 2021; 10(15).
PMID: 34362097 PMC: 8346981. DOI: 10.3390/jcm10153313.